Fineline Cube

Follow:
14398 Articles
Jiangsu Hengrui's SHR2554 Gets Priority Review for Lymphoma Treatment, Strengthening Global EZH2 Inhibitor Market
CompanyDrug

Jiangsu Hengrui’s SHR2554 Gets Priority Review for Lymphoma Treatment, Strengthening Global EZH2 Inhibitor Market

Jiangsu Hengrui Secures FDA Nod for Generic Abraxane, Strengthening Oncology Portfolio
CompanyDrug

Jiangsu Hengrui Secures FDA Nod for Generic Abraxane, Strengthening Oncology Portfolio

Roche's VENTANA CLDN18 Assay Receives EU Approval, Enhances Targeted Therapy Options for Gastric Cancer
CompanyMedical Device

Roche’s VENTANA CLDN18 Assay Receives EU Approval, Enhances Targeted Therapy Options for Gastric Cancer

Biogen Gains FDA Breakthrough Status for Felzartamab in Kidney Transplant Rejection Treatment
CompanyDrug

Biogen Gains FDA Breakthrough Status for Felzartamab in Kidney Transplant Rejection Treatment

Eli Lilly & Co. Boosts Suzhou Plant with $211M to Meet Diabetes and Obesity Drug Demand
Company

Eli Lilly & Co. Boosts Suzhou Plant with $211M to Meet Diabetes and Obesity Drug Demand

China's NMPA Proposes Rewards for Internal Whistleblowers in Drug and Medical Device Safety Reporting
Legal / IPPolicy / Regulatory

China’s NMPA Proposes Rewards for Internal Whistleblowers in Drug and Medical Device Safety Reporting

Sunvozertinib's Companion Diagnostic Gets NMPA Nod, Fortifying Targeted Therapy Arsenal for NSCLC in China
CompanyDrug

Sunvozertinib’s Companion Diagnostic Gets NMPA Nod, Fortifying Targeted Therapy Arsenal for NSCLC in China

Sino Medical Sciences Secures NMPA Nod for Balloon Guided Catheter to Aid Vascular Procedures
CompanyMedical Device

Sino Medical Sciences Secures NMPA Nod for Balloon Guided Catheter to Aid Vascular Procedures

Nona Biosciences Partners with OverT Bio to Develop Next-Generation Cell Therapies for Solid Tumors
CompanyDeals

Nona Biosciences Partners with OverT Bio to Develop Next-Generation Cell Therapies for Solid Tumors

Bill & Melinda Gates Foundation Invests $17 Million in CanSino Biologics' Recombinant Polio Vaccine
CompanyDeals

Bill & Melinda Gates Foundation Invests $17 Million in CanSino Biologics’ Recombinant Polio Vaccine

InnoCare Pharma's ICP-488 Shows Promising Results in Phase II Psoriasis Study
CompanyDrug

InnoCare Pharma’s ICP-488 Shows Promising Results in Phase II Psoriasis Study

Ascletis Pharma Faces US Import Ban for NASH Drugs ASC41 and ASC43F in Trade Secrets Dispute
CompanyDrug

Ascletis Pharma Faces US Import Ban for NASH Drugs ASC41 and ASC43F in Trade Secrets Dispute